Acadia Pharmaceuticals Inc.
$4.96B- Market cap
- $4.83B
- Debt
- +$306.51M
- Cash
- −$177.70M
Capital structure 94% equity / 6% debt · EV / Revenue 4.63x · EV / EBITDA 32.90x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: ACAD stock price at discount vs ETSY $28.02 current versus $126.63 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ETSY's multiple
Implied fair value · at ACAD's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Value edge
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ACAD FY 2025 (ended Dec 31, 2025) · ETSY FY 2025 (ended Dec 31, 2025).
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 94% equity / 6% debt · EV / Revenue 4.63x · EV / EBITDA 32.90x
Capital structure 70% equity / 30% debt · EV / Revenue 2.99x · EV / EBITDA 23.86x
ETSY carries the larger enterprise value at $8.61B against $4.96B; ETSY trades on the lower EV / Revenue multiple (2.99x vs 4.63x); ETSY on the lower EV / EBITDA (23.86x vs 32.90x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ACADIA PHARMACEUTICALS INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ETSY, INC · implied price per share
Bear
$48.69
Base
$59.56
Bull
$73.73
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.25x
-2.72x
Net debt / EBITDA
Leverage against operating earnings
0.85x
4.40x
Cash and equivalents
Liquid reserves on the balance sheet
$177.70M
$1.40B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
SUPERNUS PHARMACEUTICALS, INC.
ACAD vs SUPN
Sage Therapeutics, Inc.
ACAD vs SAGE
Jazz Pharmaceuticals plc
ACAD vs JAZZ
Alkermes plc.
ACAD vs ALKS
Harmony Biosciences Holdings, Inc.
ACAD vs HRMY
Krystal Biotech, Inc.
ACAD vs KRYS
EBAY INC
ACAD vs EBAY
PDD Holdings Inc.
ACAD vs PDD
SHOPIFY INC.
ACAD vs SHOP
Wayfair Inc.
ACAD vs W
Chewy, Inc.
ACAD vs CHWY
$306.51M
$2.98B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.